uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mutanome Engineered RNA Immunotherapy (MERIT)
BioNTech AG, Erlangen, Germany..
Gustave Roussy Comprehens Canc Ctr, Nice, France..
Gustave Roussy Comprehens Canc Ctr, Nice, France..
Vrije Univ Brussel, Brussels, Belgium..
Show others and affiliations
2015 (English)In: HUMAN GENE THERAPY CLINICAL DEVELOPMENT, ISSN 2324-8637, Vol. 26, no 2, 84-86 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2015. Vol. 26, no 2, 84-86 p.
National Category
Medical Genetics Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-265946DOI: 10.1089/humc.2015.2524ISI: 000362315000006OAI: oai:DiVA.org:uu-265946DiVA: diva2:866918
Funder
EU, European Research Council, 601939
Available from: 2015-11-04 Created: 2015-11-04 Last updated: 2015-11-04Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Sjöblom, TobiasLindman, Henrik

Search in DiVA

By author/editor
Sjöblom, TobiasLindman, Henrik
By organisation
Experimental and Clinical Oncology
Medical GeneticsCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 575 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf